Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Yeast and drug discovery.

Timothy R Hughes¹

¹Banting and Best Department of Medical Research, University of Toronto, 112 College St., Toronto, ON M5G 1L6, Canada. t.hughes@utoronto.ca

Functional & Integrative Genomics

|August 23, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Anti-Atherogenic Actions of Pomegranate Polyphenol Punicalagin and Its Metabolites: In Vitro Effects on Vascular Cells and In Vivo Atheroprotection by Urolithin A via Anti-Inflammatory and Plaque-Stabilising Mechanisms.

Antioxidants (Basel, Switzerland)·2026

Same author

The impact of the Lab4 probiotic on neurodegenerative processes in a murine Alzheimer's disease model.

Frontiers in neuroscience·2026

Same author

Resveratrol Mediates Anti-Atherogenic Actions In Vitro and in LDL Receptor-Deficient Mice Fed a High-Fat Diet via Antioxidant, Anti-Inflammatory and Plaque-Stabilising Activities.

Antioxidants (Basel, Switzerland)·2026

Same author

Inferring binding specificities of human transcription factors with the wisdom of crowds.

bioRxiv : the preprint server for biology·2025

Same author

Differential usage of two, distinct DNA-binding domains regulates tissue-specific occupancy of the pioneer factor Zelda.

bioRxiv : the preprint server for biology·2025

Same author

Absence of complement terminal pathway activity in C6-deficient mice prolongs survival in a mouse model of severe malarial infection.

Immunobiology·2025

Same journal

Positive regulatory role of EuWRKY1 in the biosynthesis of Eucommia ulmoides rubber.

Functional & integrative genomics·2026

Same journal

Environmental enrichment modulates, but does not normalize, aging-associated immune transcriptional programs after ischemic stroke.

Functional & integrative genomics·2026

Same journal

A hypoxia-responsive migrasome-related lncRNA signature predicts prognosis and suggests the MSC-AS1/ITGA5 axis as a potential therapeutic target in head and neck squamous cell carcinoma.

Functional & integrative genomics·2026

Same journal

Genome-wide exploration of biosynthetic gene clusters and their association with virulence in the entomopathogenic fungus Beauveria.

Functional & integrative genomics·2026

Same journal

Single-cell transcriptomic analysis identifies a tumor-enriched GIMAP7⁺ CD4⁺ naïve T cell population with a unique immunoregulatory state in lung adenocarcinoma.

Functional & integrative genomics·2026

Same journal

Integrating artificial intelligence and multi-omics data for precision oncology in endometrial cancer: a narrative review.

Functional & integrative genomics·2026

See all related articles

Saccharomyces cerevisiae, or yeast, is a powerful tool for discovering new antifungal drugs. Its genetic tractability and conservation of cellular processes make it ideal for drug screening and target identification, with future potential yet to be fully explored.

Area of Science:

Biochemistry
Genetics
Microbiology

Background:

The yeast Saccharomyces cerevisiae is a model organism with conserved cellular processes.
It is genetically tractable and closely related to the human pathogen Candida albicans.

Purpose of the Study:

To highlight the utility of Saccharomyces cerevisiae in antifungal drug discovery.
To discuss its role in identifying drug targets and screening compounds.
To analyze the cellular effects of drugs.

Main Methods:

Utilizing advanced genetic techniques in yeast.
Employing target-based and non-target-based drug screening.
Analyzing cellular responses to therapeutic compounds.

Main Results:

Related Experiment Videos

Yeast serves as a valuable system for drug target identification.
It facilitates both target-based and non-target-based drug screening.
Detailed analysis of drug effects on cellular processes is achievable.

Conclusions:

Saccharomyces cerevisiae offers significant advantages for antifungal drug discovery.
The full potential of yeast in therapeutic compound development is yet to be realized.
Continued research is expected to yield further benefits in drug discovery.